This month’s focus on pharmaphorum is clinical trials, so who better to share their view on global clinical trials than Zheng Su, Editor-in-Chief of the Contemporary Clinical Trials journal.

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

Blockchain is a safe and secure platform for storing and processing all types of valuable information, from clinical trial analysis results to business workflow documents to patients’ medical ...

The global market for Clinical Trial Supply and Logistics was valued ... This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed ...

Cedars-Sinai researchers have developed a novel nutritional formula, mBiota Elemental, a palatable elemental diet (PED) that ...

A plain language summary for patients explains there were no differences in safety outcomes between adalimumab-adbm and the ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

The MHRA believes this is the first analysis conducted by a UK regulator to evaluate clinical trial submissions. Between February 2019 and October 2023, the MHRA Clinical Trials Unit (CTU) received ...

In clinical trials, researchers face many obstacles that make it very difficult to show whether a potential treatment works or is better than the current treatment. The goal of the Lupus Foundation of ...

KYOTO—Researchers have safely transplanted nerve cells generated from induced pluripotent stem (iPS) cells into the brains of ...

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...